RTI Biologics, Inc.Senior Financial Analyst
Oct. 2004 - Jan. 2009Appx $750M of annual revenue.
• Prepared timely and accurate SEC filings (10K, 10Q, 8K, Proxy, S-3) and ensured compliance with GAAP.
• Collaborated with Board of Directors and external auditors on the creation and maintenance of monthly and quarterly reports, analysis and scorecards as well as internal reports utilizing FRx, Solomon and SQL. • Performed IFRS/FASB, XBRL, and Black-Scholes research to ensure the compliance requirements are met.
• Involved heavily in matters for the company which included international and US GAAP reporting, U.S. operation financial closings, Sarbanes-Oxley reporting and compliance, tax reporting and compliance, 401k reporting, Fair Value calculations, stock options accounting, and assisting with consolidations.
• Conducted extensive research into SEC and IRS compliance requirements and any associated tax changes.
• Prepared, implemented, and monitored all annual and monthly budgets for each department in the company as well as made financial statement presentations.
• Reorganized reporting tools to increase accuracy, preparation time, and relevance.
• Reduced monthly close from 13 days down to 6 by identifying key areas for improvement and then implementing streamlined processes.
• Finalized budget preparation to December from March, and implementation to January from April.
• Reviewed mid-month expenses by department to oversee budget compliance, and decreased budget variances by 7%.
• Successfully trained Financial Analyst to perform internal reporting function when promoted.
• Brought cash flow reporting and state income tax preparation in-house, saving the company CPA fees.